tbuckley/cabot-search huggingface dataset:
SAT-421 The reversal of MASH cirrhosis. Pooled analysis from RCTs
Authors: Henrik Hee Seung Yang, Cheng Han Ng, Donghyun Ko, Daniel Huang, Mazen Moureddin, Wenhao Li, Hirokazu Takahashi, Asahiro Morshita, Mark Muthiah
Journal: Journal of Hepatology (2025)
THU-029 Awareness of metabolic dysfunction-associated steatotic liver disease (MASLD) in four cities in the United States, including among people with diabetes and primary care providers
Authors: Trenton M White, Scott Isaacs, Norah Terrault, Mary E. Rinella, Alina M Allen, Naim Alkhouri, Meena Bansal, Michael Charlton, Ira Jacobson, Sonal Kumar, Mazen Noureddin, Silvana Pannain, Ayman El-Mohandes, Jeffrey Lazarus
Journal: Journal of Hepatology (2025)
WED-497 Steatotic liver disease as a mortality risk enhancer in the presence of metabolic syndrome
Authors: Guyu Zeng, Peizhi Wang, WeiWei Xu, Qinxue Li, Tianyu Li, Yue Tian, Bochuan Huang, Diederick Grobbee, Manuel Castro Cabezas, Jinqing Yuan
Journal: Journal of Hepatology (2025)
TOP-427 Characterizing the response to high-dose gene therapy in nonhuman primates with a healthy or fibrotic liver at single nucleus resolution
Authors: Joanne Hsieh, Linda Chio, Jingshu Chen, Vinay Kartha, Heather Burkart, Susan Appt, Daniel Fuentes, Chris Carrico, Amber Lim, Smitha Shambhu, Dimitry Popov, Kylie Kavanagh, Chris Towne, Martin Borch Jensen
Journal: Journal of Hepatology (2025)
FRI-334 Adaptative immune activation as a biomarker of Metabolic dysfunction-associated steatotic liver disease severity
Authors: Adriana Martínez-Cuazitl, Eira Cerda Reyes, Stefanny Cornejo-Hernández, Esquivel-Alarcón Esly, Mata-Miranda Monica Maribel, Vazquez-Zapien Gustavo Jesús, Juan Salvador García-Hernandez, Hernandez-Espinosa Reina, García-Araiza Mayra Gabriela
Journal: Journal of Hepatology (2025)
FRI-337 ETX-312, a GalOmic siRNA for the treatment of MASH, effectively improves the MASH phenotype of GAN DIO-MASH mice alone or in combination with emerging therapies
Authors: Gaye Saginc Giannoustas, Natalie Pursell, Alexandre Debacker, Damian Elle, Alan Whitmore
Journal: Journal of Hepatology (2025)
FRI-031 Performance of chronic liver disease questionnaire – metabolic dysfunction-associated steatohepatitis (CLDQ-MASH) against non-invasive tests
Authors: Zobair Younossi, Yusuf Yilmaz, Ming-Lung Yu, Mohamed El-Kassas, Marlen Ivon Castellanos Fernández, Yuichiro Eguchi, George Papatheodoridis, Vincent Wai-Sun Wong, Ajay Kumar Duseja, Ashwani K. Singal, Saeed Sadiq Hamid, Elisabetta Bugianesi, Vasily Isakov, Manuel Romero-Gómez, Wah-Kheong Chan, Khalid A Alswat, Jiangao Fan, Stuart C Gordon, Stuart Roberts, Jacob George, Nahum Méndez-Sánchez, Caglayan Keklikkiran, Eugen Tcaciuc, Racila Andrei, Brian Lam, Linda Henry, Andrei Racila, Maria Stepanova, Saleh Alqahtani
Journal: Journal of Hepatology (2025)
THU-433-YI The impactof cardiopulmonary fitness on metabolic dysfunctionassociated steatotic liver disease in a combined lifestyle intervention for adolescents with obesity
Authors: Maarten Buytaert, Ilse Coomans, Ellen Dupont, Kristof Vandekerckhove, Sander Lefere, Ruth de Bruyne
Journal: Journal of Hepatology (2025)
FRI-344 Sexual dimorphism of Sprague-Dawley rats in the liver inflammatory/fibrotic response to a high in sucrose and fat, choline-deficient, L-amino acid CDAA diet
Authors: Patricia Ramírez-Carrasco, Manel Garcia-Díez, Jianing Zhou, Yanhao Qiu, Roger Bentanachs, Marta Alegret, Laia Vilà, Núria Roglans, Juan Carlos Laguna
Journal: Journal of Hepatology (2025)
FRI-290 NTCP intronic polymorphism rs17556915 had no impact on HDV RNA levels and bulevirtide response in patients treated with bulevirtide
Authors: Yang Liu, Gabriel Cuellar-Partida, Simin Xu, Thomas Aeschbacher, Ross Martin, Savrina Manhas, Dmitry Manuilov, Renee-Claude Mercier, Amos Lichtman, Jenny Svarovskaia, Hongmei Mo, Pietro Lampertico
Journal: Journal of Hepatology (2025)
WED-375 Relevant incidental histologic diagnoses in MASLD patients enrolled in the NASH CRN
Authors: Daniela Allende, Patricia Belt, Laura Wilson, Cynthia Behling, Ryan Gill, Cynthia Guy, Danielle Carpenter, Oscar Cummings, Bryce Hatfield, Matthew Yeh, David E Kleiner
Journal: Journal of Hepatology (2025)
WED-365 Does measuring the components of the Fibrosis-4 index (FIB-4) separately on different days affect its diagnostic and prognostic performance in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)?
Authors: Sherlot Juan Song, Vincent Wai-Sun Wong, Jennifer Kramer, Jimmy Lai, Grace Lai-Hung Wong, Fasiha Kanwal, Terry Cheuk-Fung Yip
Journal: Journal of Hepatology (2025)
FRI-438 Identification of differences in therapeutic mechanisms between Resmetirom and Semaglutide on metabolic dysfunction-associated steatohepatitis treatment in western diet-fed melanocortin 4 receptor knockout mice
Authors: Takumi Sugawara, Kosuke Hitaka, Mitsuharu Matsumoto, Yumiko Miyamoto, Hitoshi Kandori, Kotaro Yokoyama, Yasunori Nio
Journal: Journal of Hepatology (2025)
FRI-435 Increased nuclear localization of small heterodimer partner despite incresed serum BA profile in patients with metabolic dysfunction-associated steatohepatitis
Authors: Shih-Chieh Chien, Chiung-Yu Chen, Hong-Wen Tsai, Yih-Jyh Lin, Shu-Chu Shiesh, Pin-Nan Cheng, Chiu Hung-Chih, Yencheng Chiu, Mei-Juan Zheng, Ming-Shan Wu, Kung-Chia Young, Yau-Sheng Tsai
Journal: Journal of Hepatology (2025)
FRI-099 Systematic review of stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma with tumor thrombus extension to the inferior vena cava or right atrium
Authors: Divya Khosla, Treshita Dey, Rakesh Kapoor, Deepti Sharma, Renu Madan, Shikha Goyal
Journal: Journal of Hepatology (2025)
WED-371 ALT is an effective screening tool for advanced MASLD in children with obesity and overweight
Authors: Anne-Sophie Stroes, Laura Draijer, Malika Chegary, Felix Kreier, Erim van Os, Joery Goede, Venje Boonstra, Ilse Westerbeek, Saskia Bouma, Meeike Kusters, Roosje Roelants, Ulrich Beuers, A.G. (Onno) Holleboom, Marc Benninga, Bart Koot
Journal: Journal of Hepatology (2025)
FRI-115 Improving outcomes in unresectable hepatocellular carcinoma through proactive adverse event management with Atezolizumab-Bevacizumab therapy
Authors: Jeayeon Park, Dong Ho Lee, Moon Haeng Hur, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Yoon Jun Kim, Jung-Hwan Yoon, Su Jong Yu
Journal: Journal of Hepatology (2025)
FRI-383 Comparative anti-fibrotic action of resmetirom, semaglutide, tirzepatide and efruxifermin in the GAN diet-induced obese and biopsy-confirmed mouse model of MASH
Authors: Jacob Nøhr-Meldgaard, Gaye Saginc Giannoustas, Natalie Pursell, Malte H. Nielsen, Susanne Pors, Michael Feigh
Journal: Journal of Hepatology (2025)
FRI-088 Exosomal miR-30a-5p: a promising biomarker for predicting response to Atezolizumab-Bevacizumab therapy in advanced hepatocellular carcinoma
Authors: Eunho Choi, Young-Sun Lee, Jeong-An Gim, Wonhyo Seo, Ha Seok Lee, Youngwoo Lee, Yang Jae Yoo, Seong Hee Kang, Sun Young Yim, Young Kul Jung, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun
Journal: Journal of Hepatology (2025)
ABCC3 Is a Differential Marker of CYP11B2-Negative Zona Glomerulosa Cells in Human Adrenal Cortex
Authors: Yingxian Pang, Sanas Mir-Bashiri, Zhuolun Sun, Yuhong Yang, Isabella Castellano, Thomas Knösel, Martin Reincke, Tracy Ann Williams
Journal: Endocrine Pathology (2025)
SAT-402 Combination of pharmacological and surgical interruption of the enterohepatic circulation can treat cholestasis and pruritus in patients with progressive familial intrahepatic cholestasis types 1 and 2 who proved unresponsive to either treatment alone
Authors: Willem Lexmond, Frank Bodewes, JBF Hulscher, Henkjan J. Verkade
Journal: Journal of Hepatology (2025)
WED-381 Identifying risk factors for “major liver-related outcomes” in patients with metabolic dysfunction-associated steatotic liver disease
Authors: Anastasia Raptis, Niharika Jakhar, Tobias Seibel, Jan Clusmann, Paul-Henry Koop, Ali Canbay, Kai Markus Schneider, Carolin V. Schneider
Journal: Journal of Hepatology (2025)
THU-413 Metabolic-dysfunction associated steatotic liver disease in inflammatory bowel disease: prevalence and progression
Authors: Grazia Pennisi, Emanuele Bracciamà, Francesca Di Giorgio, Piera Melatti, Livia Amato, Ivan Alberto Salerno, Roberto Ajovalasit, Lavinia Di Prima, Simone Scalia, Domenico Gambadauro, Salvatore Petta, Maria Cappello
Journal: Journal of Hepatology (2025)
WED-403 Evaluation of liver fibrosis by FIB4, liver stiffness (Fibroscan, ShearWave), LiverRisk score and EASL 2-step approach in a cohort of 1169 patients (STEATOLIB) followed for MASLD
Authors: Denis Ouzan, maeva guillaume, Guillaume Penaranda, Annie Lim, Pauline Guillouche, Matthieu Guivarch, Carine Chagneau Derrode, Delasalle Patrick, Boussoukaya Samy, Maeva Salimon, Bertrand Hanslik, Jacques Liautard, Patrick Dukan, Patrick Ingiliz, Dann Ouizeman, Corinne Bonny, David Ancel, Anne-Marie Marion-Audibert, Emmanuel Debono, Thierry Fontanges, Mélanie Vallin, Pierre Toulemonde, Olivier Guillaud
Journal: Journal of Hepatology (2025)
THU-504-YI Negative consequences of screening for steatotic liver disease
Authors: Helle Lindholm Schnefeld, Johanne Kragh Hansen, Katrine Bech, Anita Arslanow, Isabel Graupera, Katrine Prier Lindvig, Katrine Thorhauge, Stine Johansen, Mads Israelsen, Ida Falk Villesen, Peter Andersen, Nikolaj Torp, Sönke Detlefsen, Núria Fabrellas, Pere Gineès, Aleksander Krag, Maja Thiele
Journal: Journal of Hepatology (2025)
TOP-394 Comprehensive analysis of biomarker performance targeting “advanced fibrosis” and “at-risk” metabolic-dysfunction associated steatotic liver disease (MASH) – primary analysis of the LITMUS study cohort
Authors: Yasaman Vali, Kristy Wonders, Guruprasad Aithal, Rocio Aller, Michael Allison, Johanna Arola, Jesus Maria Banales, Vanesa Bernal, Annalisa Berzigotti, Jerome Boursier, Clifford Brass, Elisabetta Bugianesi, José Luis Calleja Panero, Jeremy Cobbold, Helena Cortez-Pinto, Javier Crespo, Susan Davies, Ann Driessen, Kevin Duffin, Mattias Ekstedt, Daniel Forton, Céline Fournier-Poizat, Sven Francque, Andreas Geier, Annette Gouw, Hannes Hagström, A.G. (Onno) Holleboom, Prodromos Hytiroglou, Morten Karsdal, Carolin Lackner, Diana Julie Leeming, Jeremy Magnanensi, Rebeca Mayo, Luca Miele, George Papatheodoridis, Valérie Paradis, Michael Pavlides, Juan Manuel Pericàs, Salvatore Petta, Vlad Ratziu, Manuel Romero-Gómez, Jörn M. Schattenberg, Detlef Schuppan, Rambabu Surabattula, Ana Silva, Beate Straub, Mette Kjaer, Gianluca Svegliati-Baroni, Dina G. Tiniakos, Maria Manuela Tonini, Richard Torstenson, Luca Valenti, Joanne Verheij, David Wenn, Hannele Yki-Järvinen, Carla Yunis, Patrick Bossuyt, Quentin M. Anstee
Journal: Journal of Hepatology (2025)
THU-374 Longitudinal dynamics and predictors of hepatic fibrosis and steatosis in people living with HIV: an egyptian cohort study
Authors: Rahma Mohamed, Ahmed Kamel, Naeema El Garhy, Lamiaa Al Sehemy, Mohamed Nagy, Andrew Saweres, Remon Atef, Reham Awad Awad, Rana Marwan, Engy El Khateeb, Zeinab Elsaadany, Zainab Masoud, Rania Hamza, Hend Tamim, Mona Hamdy, Amal Sayed, Gamal Esmat, Ahmed Cordie
Journal: Journal of Hepatology (2025)
THU-408 The impact of first and further decompensation in patients with metabolic-dysfunction associated compensated advanced chronic liver disease
Authors: Grazia Pennisi, Gabriele Di Maria, Vincent Wai-Sun Wong, Victor de Ledinghen, Giada Sebastiani, Mauro Viganò, Anna Ludovica Fracanzani, Luca Miele, Elisabetta Bugianesi, Mattias Ekstedt, Roberta D’Ambrosio, Federico Ravaioli, Filippo Schepis, Fabio Marra, Alessio Aghemo, Gianluca Svegliati-Baroni, Marcello Persico, Luca Valenti, Annalisa Berzigotti, Jacob George, Angelo Armandi, Vincenza Calvaruso, Marco Enea, Huapeng Lin, Giuseppe Infantino, Mario Masarone, Nicola Pugliese, Adele Tulone, Vito Di Marco, Calogero Camma, Salvatore Petta
Journal: Journal of Hepatology (2025)
SAT-424 Baseline characteristics in well-compensated NASH cirrhosis patients diagnosed with or without a liver biopsy in MAESTRO-NASH-OUTCOMES, a clinical outcome phase 3 study assessing the effect of resmetirom in well compensated NASH cirrhosis
Authors: Jörn M. Schattenberg, Meena Bansal, Rebecca Taub, Dominic Labriola, David Schneider, Michael Charlton, Vlad Ratziu, Mazen Noureddin
Journal: Journal of Hepatology (2025)
THU-455 Real-world assessment of clinical burden and healthcare resource utilisation among patients with metabolic dysfunctionassociated steatohepatitis with additional cardiovascular, renal and metabolic comorbidities in France, Italy, Germany and Canada
Authors: Jens U. Marquardt, Giada Sebastiani, Riku Ota, Eliza Smith, Hayley Wallinger, Kathryn Tebbs, Elisabetta Bugianesi
Journal: Journal of Hepatology (2025)
WED-388 Artificial intelligence measurement of portal tracts enables quantification of portal, lobular and interface inflammation in metabolic dysfunction-associated steatotic liver disease, metabolic dysfunction-associated steatohepatitis and autoimmune hepatitis
Authors: Dylan Windell, Alastair Magness, Paul Aljabar, Kenneth Fleming, Eve Fryer, Tim Kendall, Robert D. Goldin, Phil Wakefield, Caitlin Langford
Journal: Journal of Hepatology (2025)
SAT-079 Metabolic and functional characterization of CD8+ T-cell subpopulations in hepatocellular carcinoma: implications of tumor microenvironment on T-cell dysfunction
Authors: Anna Montali, Valentina Reverberi, Alessio Pelagatti, Andrea Vecchi, Marzia Rossi, Sara Doselli, Benedetta Farina, Andrea Olivani, Giorgio Economopoulos, Raffaelle Dalla Valle, Paola Fisicaro, Carolina Boni, Gabriele Missale
Journal: Journal of Hepatology (2025)
THU-126 So hot, yet so cold: bacterial lipopolysaccharides hinder tumor adaptive immunity by producing inflammatory and suppressive innate immunity in non- or poorly-infiltrated hepatocellular carcinoma
Authors: Lugien Al Asadi, Sylvie Job, Héloïse Halse, Alexandre Dos-Santos, Astrid Laurent Bellue, Nicolas Moniaux, Jonathan Pol, Alice Deshayes, Amelie Bigorgne, Mélodie Bonvalet, René Adam, Daniel Azoulay, Denis Castaing, Daniel Cherqui, Antonio Sa Cunha, Olivier Rosmorduc, Catherine Guettier, Eric Vibert, Aurélien Marabelle, Jamila Faivre
Journal: Journal of Hepatology (2025)
THU-113-YI Distinct roles of SOS1 and SOS2 in lipid metabolism and tumorigenesis: implications for therapeutic targeting in cancer and metabolic disorders
Authors: Andrea Olarte, Rósula García, Nuria Calzada, Enrique De la Rosa, Pablo Ramos, Carmela Gomez, Fernando Calvo, Eugenio Santos
Journal: Journal of Hepatology (2025)
SAT-095 Selective targeting of integrin avβ8 effectively suppresses tumor growth in the new PSC-associated cholangiocarcinoma model (SB CCA.Mdr2-/- mouse)
Authors: Pinzhu Huang, Wen Gao, Heansika Matta, Andrew Farag, Zaur Abilov, Disha Skelton-Badlani, Zhensheng Zhang, Maram Alenzi, Natalia Blanco, Min Lu, Blaise Lippa, Bruce Rogers, Yury Popov
Journal: Journal of Hepatology (2025)
THU-125 Activation of coagulation system and platelet aggregation in patients with primary sclerosing cholangitis and cholangiocarcinoma
Authors: Yahima Frion-Herrera, Camilla Venturin, Massimiliano Cadamuro, Giorgia Nuozzi, Claudia Maria Radu, Claudia Mescoli, Umberto Cillo, Enrico Gringeri, Elena Campello, Mario Strazzabosco, Antonio Cigliano, Diego Francesco Calvisi, Paolo Simioni, Luca Fabris
Journal: Journal of Hepatology (2025)
SAT-088 Integrated multi-omics profiling of pan heat shock proteins in hepatocellular carcinoma identifies CCT3 and CCT7 as druggable oncogenes in hepatocytes
Authors: Manju Nidagodu Jayakumar, Bilal Rah, Jasmin Shafarin, Mainak Dutta, Sainitin Donakonda, Jibran Sualeh Muhammad
Journal: Journal of Hepatology (2025)
TOP-410 When is a liver biopsy necessary? Predictive factors of autoimmune hepatitis in patients with metabolic dysfunctionassociated steatotic liver disease and positive autoantibodies
Authors: Leire Sancho, Laura Guerra, Maria del Carmen Méndez Díaz, Pilar Castillo, Miriam Romero, Araceli García-Sánchez, Marta Abadía, Javier García - Samaniego, Emily Larrea, Alejandra Rodríguez-Francisco, Gonzalo Armesto, Sara Quiñones, Antonio Olveira
Journal: Journal of Hepatology (2025)
SAT-115-YI A novel panel of Methylated DNA markers for hepatocellular carcinoma
Authors: William Chung, Daniel Cox, Fan Zhang, Boris Wong, Danny Con, Mark Ziemann, Darren Wong, Marie Sinclair, Avik Majumdar, Khashayar Asadi, Numan Kutaiba, Kelvin Lim, Mark Goodwin, Dinesh Ranatunga, Richard Khor, Sweet Ping Ng, Kumar Visvanathan, Kerry Breheney, Julie Nigro, Graham Starkey, Marcos Perini, Michael Fink, Eunice Lee, Julie Lokan, Robert Jones, Niall Tebbutt, Vijayaragavan Muralidharan, Josephine Grace, Adam Testro
Journal: Journal of Hepatology (2025)
FRI-400-YI Impact of ageing on metabolic dysfunction-associated steatotic liver disease in a murine model: insights into progression, biomarkers, and therapeutic stratification
Authors: Lucia Lameroli Mauriz, Andrea Scelza, Miranda Orellano, Juan Bayo Fina, Esteban Fiore, María José Cantero, Bárbara Bueloni, Mailín Casadei, Luz Andreone, Guillermo Mazzolini, Catalina Atorrasagasti
Journal: Journal of Hepatology (2025)
THU-417 Influence of cardiometabolic risk factors and alcohol consumption on liver stiffness in MASLD patients: a multicenter study in Colombia
Authors: Ismael de Jesus Yepes Barreto, Pablo Osorio, Nicole Chamorro, Yohana Poveda, Clara Caez, Juan Carlos Restrepo, Jorge Ortiz, Santiago Pino
Journal: Journal of Hepatology (2025)
SAT-099 The liver artificial intelligence (lai) consortium: a benchmark dataset and optimised machine learning methods for MRI-based diagnosis of solid-appearing liver lesions
Authors: Ruben Niemantsverdriet, Frederik Hartmann, Mara Veenstra, Michail Doukas, Roy Dwarkasing, Valerie Vilgrain, Maxime Ronot, Bachir Taouli, Razvan Miclea, Giuseppe Brancatelli, Maria Antonietta Bali, Jip Prince, Robbert de Haas, Vincent de Meijer, Otto van Delden, Joris Erdmann, Numan Kutaiba, Maciej Bobowicz, Lorenzo Faggioni, Karim Lekadir, Kathryn Fowler, Fredrik Illerstam, Maarten Thomeer, Stefan Klein, Martijn Starmans, LAI Consortium
Journal: Journal of Hepatology (2025)
FRI-416 Patatin-like phosphatase domain-containing 3 (PNPLA3) genotype and dietary fat modify the liver adiposity
Authors: Milla-Maria Tauriainen, Maria Lankinen, Juhana Hakumaki, Olli Lahtinen, Minna Husso, Jyrki Ågren, Markku Laakso, Ursula Schwab
Journal: Journal of Hepatology (2025)
THU-123-YI YAP activity in cancer-associated fibroblasts is relevant for immune escape in cholangiocarcinoma
Authors: Kieu Trinh Dinh, Chun-Shan Liu, Viktorie Gabrielová, Daria Komkova, Nugzar Lekiashvili, Angela Goncalves, Michael Dill
Journal: Journal of Hepatology (2025)
SAT-461-YI The early impact of bariatric surgery on liver fibrosis and steatosis in MASLD patients
Authors: Valentina Cossiga, Mario Capasso, Concetta Accongiagioco, Luisa Ranieri, Vincenzo Schiavone, Simona Albano, Alon Gregory Rutigliano, Antonio Franzese, Francesco Capozzi, Maria Guarino, Mario Musella, Filomena Morisco
Journal: Journal of Hepatology (2025)
THU-420 10 years progression of metabolic risk factors, diet quality and degree of steatosis and fibrosis in a general population cohort ECOR liver study
Authors: Joana Estrabocha, Sara Policarpo, Maria do Mar Orey, Sofia Carvalhana, Ana Craciun, Juliana Serrazina Pedro, Helena Cortez-Pinto
Journal: Journal of Hepatology (2025)
THU-446 Risk stratification of liver-related complications through unsupervised partitioning clustering of alanine aminotransferase (ALT) levels and trajectories in patients with type 2 diabetes (T2D)
Authors: Nana Peng, Sherlot Juan Song, Mary Yue Wang, Jimmy Lai, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Terry Cheuk-Fung Yip
Journal: Journal of Hepatology (2025)
WED-487 The blood-based SteatoTest-2 score identifies a previously invisible early steatosis phenotype
Authors: Thierry Poynard, Olivier Deckmyn, Raluca Pais, Valentina Peta, Judith Aron-Wisnewsky, Karine Clement, Dominique Thabut, Dominique Valla, Laurent Castera, Vlad Ratziu
Journal: Journal of Hepatology (2025)
FRI-112 Local control and survival after stereotactic body radiotherapy for hepatocellular carcinoma without macrovascular invasion
Authors: Jose Paul, Cyriac Philips, John Menachery, Sanju Cyriac, Sasidharan Rajesh, Susan John, Joseph George, Subi Subramanian, Dileep Chadrasekhar, Ayesha Jaleel, Renjith Rajan, Arun Philip, Aswin Joy, Rosh Varghese, Ajit Tharakan, Rizwan Ahamed, Tharun Tom Oommen, Vinayak Jayaram, Nimi Andrew, Akhil Baby, Anand Thomas, Vijay Harish Somasundaram, R. Anand, Nibin Nahaz, Biju Chandran, Latha Abraham, Philip Augustine
Journal: Journal of Hepatology (2025)
SAT-455 A single centre, comparative study of Saroglitazar combined with vitamin E versus Saroglitazar alone in managing steatotic liver disease and/or metabolic dysfunction among liver transplant recipients
Authors: Swapnil Dhampalwar, Narendra S Choudhary, Neeraj Saraf, Kunwar Ashish Singh, Arvinder Singh Soin
Journal: Journal of Hepatology (2025)
THU-517-YI iCARE: Insights on competency advancement and recommendations for nurses managing HBV/HDV with bulevirtide – findings from a european advisory board
Authors: Patrizia Künzler-Heule, Judit Romero-Vico, Mélanie Simoes, Martina Fellinghauer, Gemma Botterill, Samantha Readhead
Journal: Journal of Hepatology (2025)
FRI-358 Anti-inflammatory effects of a chemokine receptor mimicking peptide in obesity-associated MASH and atherosclerosis in Ldlr −/− Leiden mice
Authors: Simon Ebert, Eveline Gart, Wim van Duyvenvoorde, Markus Brandhofer, Hendrik Wunderlich, Aphrodite Kapurniotu, Robert Kleemann, Martine C. Morrison, Jürgen Bernhagen
Journal: Journal of Hepatology (2025)
FRI-241 Longitudinal analysis of viral profiles in chronic HBV/HDV coinfected patients
Authors: Cristina Musolino, Valeria Chines, Daniele Lombardo, Domenico Giosa, Maria Stella Franze, Giuseppina Raffa, Donatella Ferraro, Irene Cacciola, Vito Di Marco, Giovanni Raimondo, Teresa Pollicino
Journal: Journal of Hepatology (2025)
FRI-081 Transcatheter arterial chemoembolization combined with immune checkpoint inhibitors plus molecular targeted therapy after 125I irradiation stent placement in patients with hepatocellularcarcinoma and mainportalvein tumor thrombosis (PATENCY II)
Authors: Junhao Mei, Kaizhi Jia, Jian Lu, Gaojun Teng
Journal: Journal of Hepatology (2025)
WED-513 Role of liver and spleen stiffness in predicting hepatic decompensation following transarterial chemoembolization in patients with hepatocellular carcinoma
Authors: Chidkamon Pattarawongpaiboon, Panarat Thaimai, Nipaporn Siripon, Salisa Wejnaruemarn, Prooksa Ananchuensook, Sombat Treeprasertsuk, Piyawat Komolmit, Kessarin Thanapirom
Journal: Journal of Hepatology (2025)
THU-404 Genome-wide association study of noninvasive scores of fibrotic MASLD in an italian population
Authors: Francesco Malvestiti, Vittoria Moretti, Stefania Mira, Oveis Jamialahmadi, Serena Pelusi, Giulia Periti, Luisa Ronzoni, Lorenzo Miano, Martina Tranchina, Chiara Rosso, Grazia Pennisi, Angelo Armandi, Antonio Liguori, Francesca Terracciani, Riccardo Perbellini, Giorgio Soardo, Alessandro Federico, Umberto Vespasiani Gentilucci, Luca Miele, Elisabetta Bugianesi, Roberta D’Ambrosio, Salvatore Petta, Daniele Prati, Stefano Romeo, Luca Valenti
Journal: Journal of Hepatology (2025)
THU-461-YI Genetic risk score correlates with Cytokine expression and risk of HCC and cirrhosis in MASLD patients from Latin America
Authors: Siyu Fu, Anthony Grooshuismink, Domingo Balderramo, Angelo Z. Mattos, Enrique Carrera Estupiñan, Javier Diaz-Ferrer, Jesus Maria Banales, Jhon Prieto, Marco Arrese, Bettina E. Hansen, Jose Debes, Andre Boonstra
Journal: Journal of Hepatology (2025)
TOP-412 Long-term mortality in steatotic liver disease is greatest in those with a combination of metabolic dysfunction and excessive alcohol consumption
Authors: Zobair Younossi, James M. Paik, Aleksander Krag, Ashwani K. Singal, Robert Wong, Mário Pessoa, Shira Zelber-Sagi, Dana Ivancovsky Wajcman, Linda Henry, Saleh Alqahtani
Journal: Journal of Hepatology (2025)